JP6910751B2 - Moisturizers, anti-inflammatory agents, antioxidants, skin turnover improvers, cell activators and whitening agents - Google Patents
Moisturizers, anti-inflammatory agents, antioxidants, skin turnover improvers, cell activators and whitening agents Download PDFInfo
- Publication number
- JP6910751B2 JP6910751B2 JP2014028914A JP2014028914A JP6910751B2 JP 6910751 B2 JP6910751 B2 JP 6910751B2 JP 2014028914 A JP2014028914 A JP 2014028914A JP 2014028914 A JP2014028914 A JP 2014028914A JP 6910751 B2 JP6910751 B2 JP 6910751B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- acid
- component
- rosaceae
- peach
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000008417 skin turnover Effects 0.000 title claims description 6
- 239000003963 antioxidant agent Substances 0.000 title description 7
- 239000004909 Moisturizer Substances 0.000 title description 4
- 230000001333 moisturizer Effects 0.000 title description 4
- 229940121363 anti-inflammatory agent Drugs 0.000 title description 3
- 239000002260 anti-inflammatory agent Substances 0.000 title description 3
- 239000012190 activator Substances 0.000 title description 2
- 239000007844 bleaching agent Substances 0.000 title description 2
- 239000000284 extract Substances 0.000 claims description 103
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 42
- 235000013399 edible fruits Nutrition 0.000 claims description 41
- 230000014509 gene expression Effects 0.000 claims description 34
- 244000144730 Amygdalus persica Species 0.000 claims description 31
- 240000005809 Prunus persica Species 0.000 claims description 18
- 241000220222 Rosaceae Species 0.000 claims description 18
- 239000004480 active ingredient Substances 0.000 claims description 18
- 235000004789 Rosa xanthina Nutrition 0.000 claims description 15
- 108010035532 Collagen Proteins 0.000 claims description 9
- 102000008186 Collagen Human genes 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 229920001436 collagen Polymers 0.000 claims description 9
- 235000011446 Amygdalus persica Nutrition 0.000 claims description 7
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- 230000003020 moisturizing effect Effects 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 230000002087 whitening effect Effects 0.000 claims description 5
- 230000002708 enhancing effect Effects 0.000 claims description 4
- 102100039283 Hyaluronidase-1 Human genes 0.000 claims description 3
- 101710199679 Hyaluronidase-1 Proteins 0.000 claims description 3
- 102000000589 Interleukin-1 Human genes 0.000 claims description 2
- 108010002352 Interleukin-1 Proteins 0.000 claims description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims 1
- 102000002268 Hexosaminidases Human genes 0.000 claims 1
- 108010000540 Hexosaminidases Proteins 0.000 claims 1
- 102000005741 Metalloproteases Human genes 0.000 claims 1
- 108010006035 Metalloproteases Proteins 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- -1 ethanol) used alone Chemical class 0.000 description 43
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 37
- 239000000243 solution Substances 0.000 description 33
- 238000004519 manufacturing process Methods 0.000 description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 238000012360 testing method Methods 0.000 description 28
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 26
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 24
- 239000002537 cosmetic Substances 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 19
- 240000007594 Oryza sativa Species 0.000 description 18
- 229960005070 ascorbic acid Drugs 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 18
- 235000007164 Oryza sativa Nutrition 0.000 description 17
- 235000014113 dietary fatty acids Nutrition 0.000 description 17
- 239000000194 fatty acid Substances 0.000 description 17
- 229930195729 fatty acid Natural products 0.000 description 17
- 235000009566 rice Nutrition 0.000 description 17
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 239000011668 ascorbic acid Substances 0.000 description 15
- 239000008213 purified water Substances 0.000 description 15
- 235000010323 ascorbic acid Nutrition 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 229940058015 1,3-butylene glycol Drugs 0.000 description 13
- 235000019437 butane-1,3-diol Nutrition 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- 238000000605 extraction Methods 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 239000006210 lotion Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 8
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 8
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 8
- 229960002216 methylparaben Drugs 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 229940057995 liquid paraffin Drugs 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000001339 epidermal cell Anatomy 0.000 description 6
- 210000002950 fibroblast Anatomy 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 239000012046 mixed solvent Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000012488 sample solution Substances 0.000 description 6
- 239000002453 shampoo Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 229960000401 tranexamic acid Drugs 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- 102000016942 Elastin Human genes 0.000 description 5
- 108010014258 Elastin Proteins 0.000 description 5
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 5
- 229920001214 Polysorbate 60 Polymers 0.000 description 5
- 235000002597 Solanum melongena Nutrition 0.000 description 5
- 244000061458 Solanum melongena Species 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 229920002549 elastin Polymers 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 5
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 235000013824 polyphenols Nutrition 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 5
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 4
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 210000002469 basement membrane Anatomy 0.000 description 4
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 210000002744 extracellular matrix Anatomy 0.000 description 4
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 150000002989 phenols Chemical class 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 235000013772 propylene glycol Nutrition 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 3
- OYAQUBKYAKSHOA-UHFFFAOYSA-N 2-(2-hydroxy-5-propylphenyl)-4-propylphenol Chemical compound CCCC1=CC=C(O)C(C=2C(=CC=C(CCC)C=2)O)=C1 OYAQUBKYAKSHOA-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
- 230000002407 ATP formation Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000002211 L-ascorbic acid Substances 0.000 description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 description 3
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 3
- 150000000996 L-ascorbic acids Chemical class 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000000440 bentonite Substances 0.000 description 3
- 229910000278 bentonite Inorganic materials 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000008347 soybean phospholipid Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 2
- 102100040958 Aconitate hydratase, mitochondrial Human genes 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- 244000077995 Coix lacryma jobi Species 0.000 description 2
- 102100031162 Collagen alpha-1(XVIII) chain Human genes 0.000 description 2
- 102100039868 Cytoplasmic aconitate hydratase Human genes 0.000 description 2
- 102100032059 EMILIN-1 Human genes 0.000 description 2
- 108700039887 Essential Genes Proteins 0.000 description 2
- 108091092584 GDNA Proteins 0.000 description 2
- 102100036533 Glutathione S-transferase Mu 2 Human genes 0.000 description 2
- 102100033039 Glutathione peroxidase 1 Human genes 0.000 description 2
- 101000940068 Homo sapiens Collagen alpha-1(XVIII) chain Proteins 0.000 description 2
- 101710118630 Homocitrate dehydratase, mitochondrial Proteins 0.000 description 2
- 102000003918 Hyaluronan Synthases Human genes 0.000 description 2
- 108090000320 Hyaluronan Synthases Proteins 0.000 description 2
- 102100039285 Hyaluronidase-2 Human genes 0.000 description 2
- 101710199674 Hyaluronidase-2 Proteins 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 102100026261 Metalloproteinase inhibitor 3 Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 2
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 238000010806 PrimeScriptTM RT Reagent kit Methods 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 102100033075 Prostacyclin synthase Human genes 0.000 description 2
- 101710171478 Putative aconitate hydratase, mitochondrial Proteins 0.000 description 2
- 241000220324 Pyrus Species 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 229940069521 aloe extract Drugs 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 235000021016 apples Nutrition 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 2
- 108010032789 glutathione S-transferase Mu 2 Proteins 0.000 description 2
- 108010086596 glutathione peroxidase GPX1 Proteins 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 239000003676 hair preparation Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 235000021017 pears Nutrition 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical class O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- QVSVMNXRLWSNGS-UHFFFAOYSA-N (3-fluorophenyl)methanamine Chemical compound NCC1=CC=CC(F)=C1 QVSVMNXRLWSNGS-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- GDNTZLJAPCYKJR-UHFFFAOYSA-N 1-(4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=CC=C(OC)C=C1 GDNTZLJAPCYKJR-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- UMPSXRYVXUPCOS-UHFFFAOYSA-N 2,3-dichlorophenol Chemical compound OC1=CC=CC(Cl)=C1Cl UMPSXRYVXUPCOS-UHFFFAOYSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- ATWGXJGRRXIETI-UHFFFAOYSA-N 2,5-diacetyloxybenzoic acid Chemical compound CC(=O)OC1=CC=C(OC(C)=O)C(C(O)=O)=C1 ATWGXJGRRXIETI-UHFFFAOYSA-N 0.000 description 1
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical class OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- GWHXAZLLZVWMNI-UHFFFAOYSA-N 2-acetyloxy-5-hydroxybenzoic acid Chemical compound CC(=O)OC1=CC=C(O)C=C1C(O)=O GWHXAZLLZVWMNI-UHFFFAOYSA-N 0.000 description 1
- UPHOTCBFZHQJEK-UHFFFAOYSA-N 2-hydroxy-5-propanoyloxybenzoic acid Chemical compound CCC(=O)OC1=CC=C(O)C(C(O)=O)=C1 UPHOTCBFZHQJEK-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- HWLBIEAKJSRKOD-UHFFFAOYSA-N 2-octadecanoyloxyacetic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)=O HWLBIEAKJSRKOD-UHFFFAOYSA-N 0.000 description 1
- HXVCOQUDJKMJQY-UHFFFAOYSA-N 2-octyldodecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC HXVCOQUDJKMJQY-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- GXNGGBMNYUHZOZ-UHFFFAOYSA-N 4-(1-hydroxybutyl)phenol Chemical compound CCCC(O)C1=CC=C(O)C=C1 GXNGGBMNYUHZOZ-UHFFFAOYSA-N 0.000 description 1
- SFUCGABQOMYVJW-UHFFFAOYSA-N 4-(4-Hydroxyphenyl)-2-butanol Chemical compound CC(O)CCC1=CC=C(O)C=C1 SFUCGABQOMYVJW-UHFFFAOYSA-N 0.000 description 1
- KTXUGZHJVRHQGP-UHFFFAOYSA-N 4-Hydroxy-1-(3-pyridinyl)-1-butanone Chemical compound OCCCC(=O)C1=CC=CN=C1 KTXUGZHJVRHQGP-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- 102100026802 72 kDa type IV collagenase Human genes 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 108010009924 Aconitate hydratase Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 101000678861 Arabidopsis thaliana Aconitate hydratase 1 Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- 101710043324 EMILIN-1 Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- LMHIPJMTZHDKEW-XQYLJSSYSA-M Epoprostenol sodium Chemical compound [Na+].O1\C(=C/CCCC([O-])=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 LMHIPJMTZHDKEW-XQYLJSSYSA-M 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 241000282816 Giraffa camelopardalis Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101000745370 Homo sapiens Cytoplasmic aconitate hydratase Proteins 0.000 description 1
- 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 description 1
- 101001135385 Homo sapiens Prostacyclin synthase Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001072282 Limnanthes Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 229930182636 Magnolignan Natural products 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 102000000424 Matrix Metalloproteinase 2 Human genes 0.000 description 1
- 108010016165 Matrix Metalloproteinase 2 Proteins 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 102000001776 Matrix metalloproteinase-9 Human genes 0.000 description 1
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 1
- 108050006600 Metalloproteinase inhibitor 3 Proteins 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 235000012110 Pandanus odorus Nutrition 0.000 description 1
- 244000180021 Pandanus odorus Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710179550 Prostacyclin synthase Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 235000011402 Rosa x damascena Nutrition 0.000 description 1
- 240000004978 Rosa x damascena Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 235000001329 Ziziphus joazeiro Nutrition 0.000 description 1
- 244000158786 Ziziphus joazeiro Species 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- GWVPJQDUGPKIOI-UQKRIMTDSA-N [Na].CCCCCCCCCCCC(=O)CN[C@@H](C)C(O)=O Chemical compound [Na].CCCCCCCCCCCC(=O)CN[C@@H](C)C(O)=O GWVPJQDUGPKIOI-UQKRIMTDSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical class [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000006571 energy metabolism pathway Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 229960001123 epoprostenol Drugs 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- SUSRLLXAXAIZPH-OBPIAQAESA-N hydroquinone beta-D-glucopyranoside Natural products OC[C@H]1O[C@@H](Cc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O SUSRLLXAXAIZPH-OBPIAQAESA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000007758 minimum essential medium Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- WIBFFTLQMKKBLZ-SEYXRHQNSA-N n-butyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCC WIBFFTLQMKKBLZ-SEYXRHQNSA-N 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000011506 response to oxidative stress Effects 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OZLXDDRBXFHZNO-UHFFFAOYSA-N tetraoctyl silicate Chemical compound CCCCCCCCO[Si](OCCCCCCCC)(OCCCCCCCC)OCCCCCCCC OZLXDDRBXFHZNO-UHFFFAOYSA-N 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、生体安全性にすぐれ、化粧料(医薬部外品も含む)や美容用経口組成物に配合される機能性材料に関する。 The present invention relates to a functional material having excellent biosafety and which is blended in cosmetics (including quasi-drugs) and cosmetological oral compositions.
皮膚の老化は、加齢に伴う細胞増殖・分化の不活化、ホルモン分泌の低下、細胞外マトリックス成分の量的低下などの内的要因と、太陽光(紫外線)に誘発される活性酸素、化学物質、又は環境ストレス等などの外的要因とが複雑に絡み合って生ずる現象である。それらのうち、外的要因である紫外線や化学物質は、皮膚の細胞や組織にダメージを与えて生体成分を変質させ、その結果、皮膚内に抗原を発生させる要因となる可能性がある。このことから、それらの外的要因は、抗原による皮膚の炎症やアレルギーの発症の要因となり、さらにはメラニン色素の異常沈着を誘発してシミ、ソバカス、肝斑などを生じさせるなど、肌に様々なダメージを与える。 Skin aging is caused by internal factors such as inactivation of cell proliferation and differentiation with aging, decreased hormone secretion, and quantitative decrease of extracellular matrix components, as well as active oxygen and chemistry induced by sunlight (ultraviolet rays). It is a phenomenon that occurs when substances or external factors such as environmental stress are intricately intertwined. Among them, ultraviolet rays and chemical substances, which are external factors, may damage cells and tissues of the skin and alter biological components, resulting in the generation of antigens in the skin. From this, these external factors cause skin inflammation and allergies caused by antigens, and also induce abnormal deposition of melanin pigment to cause spots, freckles, chloasma, etc. on the skin. Inflicts damage.
以上の要因に生じる皮膚の老化を防ぎ、皮膚を健全、かつ、若々しい状態に保持するため、従来、種々の活性成分の使用が提案され、それら活性成分を配合した化粧品や経口用組成物が上市されている。例えば、ビタミンC類、ビタミンE類などの抗酸化剤;グリチルリチン酸などの抗炎症剤;各種紫外線吸収剤;α−ヒドロキシカルボン酸、胎盤抽出液、γ−アミノ−β−ヒドロキシ酪酸などの細胞賦活成分;コラーゲン、エラスチン、ヒアルロン酸などの細胞外マトリックス成分;尿素などの保湿剤が提案されている。しかし、従来の活性成分では、有効性及び生体安全性の双方を十分に満足させることが困難であり、かかる点が改善された機能性原料が求められている。 In order to prevent skin aging caused by the above factors and keep the skin healthy and youthful, the use of various active ingredients has been proposed in the past, and cosmetics and oral compositions containing these active ingredients have been proposed. Is on the market. For example, antioxidants such as vitamin C and vitamin E; anti-inflammatory agents such as glycyrrhizic acid; various ultraviolet absorbers; cell activation such as α-hydroxycarboxylic acid, placenta extract, and γ-amino-β-hydroxybutyric acid. Ingredients; extracellular matrix components such as collagen, elastin, hyaluronic acid; moisturizers such as urea have been proposed. However, it is difficult for conventional active ingredients to sufficiently satisfy both efficacy and biosafety, and there is a demand for a functional raw material having improved such points.
本発明者らは、かかる従来技術の問題点に鑑みて、生体安全性の観点から天然物由来の新たな活性成分を見出すべく鋭意研究を行った。その結果、バラ科サクラ(モモ)属の植物であるモモの未成熟果実の抽出物が、すぐれた美肌作用及び美白作用を示し、当該抽出物を配合することで生体安全性及び有効性にすぐれた化粧料や美容用経口組成物の提供が可能になることを見出した。 In view of the problems of the prior art, the present inventors have conducted diligent studies to find a new active ingredient derived from a natural product from the viewpoint of biosafety. As a result, the extract of the immature fruit of peach, which is a plant belonging to the genus Sakura (Peach) of the Rosaceae family, exhibits excellent skin-whitening and whitening effects, and by blending the extract, it is excellent in biosafety and effectiveness. We have found that it will be possible to provide cosmetics and oral cosmetic compositions.
バラ科植物であるモモの栽培過程においては、果実の結実数や大きさを調製するために、未成熟果実を間引く作業、すなわち、「摘果」と呼ばれる作業が行われる。このため、モモの中でも、これら間引かれる未成熟果実を有効利用することが求められていた。 In the process of cultivating peaches, which are Rosaceae plants, the work of thinning out immature fruits, that is, the work called "fruit thinning" is performed in order to adjust the number and size of fruit fruits. Therefore, among peaches, it has been required to effectively utilize these thinned immature fruits.
従来、バラ科サクラ(モモ)属の植物であるモモの種子(桃仁)又は花の抽出物を有効成分とする化粧料が公知である(特許文献1,2)。また、未成熟のモモの果実がエラスターゼ活性阻害作用を有することは公知である(特許文献3)。さらに、バラ科植物(リンゴ、ナシ、モモ)の未成熟果実由来のポリフェノールを有効成分とする経口用又は外用の組成物も公知である(特許文献4,5)。しかし、モモの未成熟果実の抽出物自体が、保湿作用、抗炎症作用、抗酸化作用、皮膚のターンオーバー改善作用、細胞活性化作用及び美白作用を有し、これを配合することで、有効性にすぐれた化粧料や美容用経口組成物を提供することができることについては何ら知られていなかった。 Conventionally, cosmetics containing peach seeds (peach seeds) or flower extracts, which are plants belonging to the genus Sakura (peach) of the Rosaceae family, as active ingredients are known (Patent Documents 1 and 2). Further, it is known that immature peach fruits have an elastase activity inhibitory action (Patent Document 3). Further, oral or external compositions containing polyphenols derived from immature fruits of Rosaceae plants (apples, pears, peaches) as active ingredients are also known (Patent Documents 4 and 5). However, the immature fruit extract of peach itself has a moisturizing effect, an anti-inflammatory effect, an antioxidant effect, a skin turnover improving effect, a cell activating effect and a whitening effect, and it is effective to combine these. Nothing was known about the ability to provide sexually superior cosmetics or cosmetological oral compositions.
本発明は、バラ科サクラ属のモモの未成熟果実の抽出物を有効成分とする保湿剤である。
また、本発明は、バラ科サクラ属のモモの未成熟果実の抽出物を有効成分とする抗炎症剤である。
また、本発明は、バラ科サクラ属のモモの未成熟果実の抽出物を有効成分とする抗酸化剤である。
また、本発明は、バラ科サクラ属のモモの未成熟果実の抽出物を有効成分とする皮膚のターンオーバー改善剤である。
また、本発明は、バラ科サクラ属のモモの未成熟果実の抽出物を有効成分とする細胞活性化剤である。
また、本発明は、バラ科サクラ属のモモの未成熟果実の抽出物を有効成分とする美白剤である。
The present invention is a moisturizer containing an extract of immature fruits of peaches of the genus Plum of the Rosaceae family as an active ingredient.
Further, the present invention is an anti-inflammatory agent containing an extract of immature fruits of peaches of the genus Plum of the Rosaceae family as an active ingredient.
Further, the present invention is an antioxidant containing an extract of immature fruits of peaches of the genus Plum of the Rosaceae family as an active ingredient.
Further, the present invention is a skin turnover improving agent containing an extract of immature fruits of peaches of the genus Plum of the Rosaceae family as an active ingredient.
Further, the present invention is a cell activator containing an extract of immature fruits of peaches of the genus Plum of the Rosaceae family as an active ingredient.
Further, the present invention is a whitening agent containing an extract of immature fruits of peaches of the genus Plum of the Rosaceae family as an active ingredient.
本発明によれば、有効成分であるモモの未成熟果実の抽出物が保湿作用、抗炎症作用、抗酸化作用、皮膚のターンオーバー改善作用、細胞活性化作用及び美白作用の相乗作用により、すぐれた化粧料や美容用経口組成物の配合剤を提供することができる。加えて、当該抽出物は天然物由来のものであるため、生体安全性にすぐれた化粧料や美容用経口組成物を提供することもできる。 According to the present invention, the extract of immature fruit of peach, which is an active ingredient, is excellent due to the synergistic action of moisturizing action, anti-inflammatory action, antioxidant action, skin turnover improving action, cell activating action and whitening action. It is possible to provide a combination drug of a cosmetic or an oral composition for beauty. In addition, since the extract is derived from a natural product, it is possible to provide cosmetics and cosmetological oral compositions having excellent biosafety.
以下、本発明について詳細に説明する。なお、本明細書において化粧料なる文言は、所謂化粧料のほかに医薬部外品までも含む広義で用いる。
本発明で用いるバラ科サクラ属のモモ(Prunus persica)の品種は、特に限定されるものではなく、例えば、白鳳、日川白鳳、八幡白鳳、清水白桃、まさひめ、川中島白桃、大久保、あかつき、浅間白桃が挙げられ、いずれの品種のモモを使用しても良い。
Hereinafter, the present invention will be described in detail. In this specification, the term cosmetics is used in a broad sense to include not only so-called cosmetics but also quasi-drugs.
The varieties of Plum (Prunus persica) of the Rosaceae family used in the present invention are not particularly limited. , Asama white peach, and any varieties of peach may be used.
また、本発明で云うモモの未成熟果実とは、その直径が0.5〜5cm、好ましくは2〜3cmのものを指す。 The immature peach fruit referred to in the present invention refers to a fruit having a diameter of 0.5 to 5 cm, preferably 2 to 3 cm.
抽出物の調製は、モモの未成熟果実を、必要ならば予め水洗して異物を除いた後、そのまま又は乾燥した上、必要に応じて細切又は粉砕し、浸漬法等の常法に従って抽出溶媒と接触させることで行うことが可能である。 To prepare the extract, immature peach fruits are washed with water in advance to remove foreign substances, if necessary, dried as they are or dried, and then chopped or crushed as necessary, and extracted according to a conventional method such as a dipping method. This can be done by contacting with a solvent.
抽出溶媒としては、水;メタノール、エタノール、プロパノールなどの低級アルコール類;エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリンなどの多価アルコール類;酢酸エチル、酢酸ブチル、プロピオン酸メチルなどのエステル類;アセトン、メチルエチルケトンなどのケトン類;エチルエーテル、イソプロピルエーテルなどのエーテル類;n−ヘキサン、トルエン、クロロホルムなどの炭化水素系溶媒などが挙げられ、それらは単独で又は二種以上混合して用いられる。 Extraction solvents include water; lower alcohols such as methanol, ethanol and propanol; polyhydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol and glycerin; ethyl acetate, butyl acetate, methyl propionate and the like. Esters; ketones such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; hydrocarbon solvents such as n-hexane, toluene and chloroform, etc., which may be used alone or in admixture of two or more. Used.
それら抽出溶媒のうちでも、本発明においては水、低級アルコール類又は多価アルコール類などの親水性溶媒が好適である。この親水性溶媒を用いる場合の好ましい例としては、例えば、水もしくは低級アルコール類(特にエタノール)の単独使用、水と低級アルコール類(特にエタノール)との混合溶媒、又は水と多価アルコール類(特に1,3−ブチレングリコールもしくはプロピレングリコール)との混合溶媒の使用等が挙げられるが、なかでも水の単独使用が最も好ましい。混合溶媒を用いる場合の混合比は、例えば水とエタノールとの混合溶媒であれば、容量比(以下同じ)で1:1〜25:1、水とグリセリンとの混合溶媒であれば1:1〜20:1、水と1,3−ブチレングリコールとの混合溶媒であれば、1:1〜20:1の範囲とすることが好ましい。 Among these extraction solvents, hydrophilic solvents such as water, lower alcohols and polyhydric alcohols are suitable in the present invention. Preferred examples of using this hydrophilic solvent include, for example, water or lower alcohols (particularly ethanol) used alone, a mixed solvent of water and lower alcohols (particularly ethanol), or water and polyhydric alcohols (particularly ethanol). In particular, the use of a mixed solvent with 1,3-butylene glycol or propylene glycol) can be mentioned, but the use of water alone is most preferable. When a mixed solvent is used, for example, in the case of a mixed solvent of water and ethanol, the volume ratio (hereinafter the same applies) is 1: 1 to 25: 1, and in the case of a mixed solvent of water and glycerin, 1: 1. In the case of a mixed solvent of ~ 20: 1, water and 1,3-butylene glycol, the range is preferably 1: 1 to 20: 1.
抽出物の調製に際して、抽出物のpHに特に限定はないが、一般には4〜8の範囲とすることが好ましい。かかる意味で、必要であれば前記抽出溶媒に、水酸化ナトリウム、炭酸ナトリウム、水酸化カリウムなどのアルカリ性調整剤を配合し、所望のpHとなるように調整してもよい。 When preparing the extract, the pH of the extract is not particularly limited, but is generally preferably in the range of 4 to 8. In this sense, if necessary, an alkali adjusting agent such as sodium hydroxide, sodium carbonate, or potassium hydroxide may be added to the extraction solvent to adjust the pH to a desired level.
抽出温度、抽出時間等の抽出条件は、用いる溶媒の種類やpHによっても異なるが、例えば水を抽出溶媒とする場合であれば、抽出温度は0〜85℃の範囲が好ましく、また、抽出時間は、2〜3時間の範囲が好ましい。 Extraction conditions such as extraction temperature and extraction time differ depending on the type and pH of the solvent used. For example, when water is used as the extraction solvent, the extraction temperature is preferably in the range of 0 to 85 ° C., and the extraction time. Is preferably in the range of 2 to 3 hours.
上記条件により得られる抽出物は、一般にはpHを4〜8に調整した上、これをそのまま化粧料や美容用経口組成物の配合剤として使用しても、減圧濃縮等により所望の濃度として使用しても良い。 The extract obtained under the above conditions generally has a pH adjusted to 4 to 8, and even if it is used as it is as a compounding agent for cosmetics or cosmetological oral compositions, it is used as a desired concentration by concentration under reduced pressure or the like. You may.
以上の条件により調製された抽出物は、実質的にポリフェノールを含まないことから、前記特許文献4,5に開示されているバラ科植物(リンゴ、ナシ、モモ等)の未成熟果実由来のポリフェノールと区別される。 Since the extract prepared under the above conditions does not substantially contain polyphenols, polyphenols derived from immature fruits of Rosaceae plants (apples, pears, peaches, etc.) disclosed in Patent Documents 4 and 5 above. Is distinguished from.
本発明のモモの未成熟果実の抽出物を含む化粧料(医薬部外品も含む)としては、例えば乳液、クリーム、ローション、エッセンス、パックなどの基礎化粧料、口紅、ファンデーション、リクイドファンデーション、メイクアッププレスパウダー、ほほ紅、白粉などのメイクアップ化粧料、洗顔料、ボディシャンプー、石けんなどの清浄用化粧料、シャンプー、ヘアコンディショナー、ヘアクリームなどの毛髪用化粧料、さらには浴剤等が挙げられるが、勿論これらに限定されるものではない。また、美容用経口組成物としては、美容飲料、栄養ドリンク、スポーツドリンク、ニアウォーター、ビタミン飲料、ミネラル飲料、アルコール飲料などの飲料;各種スープ類(粉末スープも含む)、乳製品、ゼリー、キャンディ、錠菓、ガム等の食品;錠剤、液状、顆粒状又はゼリー状の健康食品・飲料等に配合することができるが、本発明はこれに限るものではなく、経口摂取できる飲食品等に配合することができる。 Cosmetics (including non-medicinal products) containing the immature fruit extract of the peach of the present invention include, for example, basic cosmetics such as milky lotion, cream, lotion, essence, and pack, lipstick, foundation, liquid foundation, and makeup. Makeup cosmetics such as uppress powder, blusher, white powder, cleansing cosmetics such as face wash, body shampoo, soap, hair cosmetics such as shampoo, hair conditioner, hair cream, and bathing agents. However, of course, it is not limited to these. In addition, as oral cosmetic compositions, beverages such as beauty beverages, nutritional drinks, sports drinks, near water, vitamin beverages, mineral beverages, alcoholic beverages; various soups (including powdered soups), dairy products, jellies, candy , Tablets, gums and other foods; can be blended in tablets, liquids, granules or jelly-like health foods / beverages, etc. can do.
化粧料におけるモモの未成熟果実の抽出物の配合量は、抽出物の固形分として、基礎化粧料の場合は、一般に0.002〜1.0重量%、好ましくは0.02〜0.2重量%の範囲、メイクアップ化粧料の場合は、一般に0.002〜1.0重量%、好ましくは0.02〜0.2重量%の範囲、又清浄用化粧料の場合は、一般に0.002〜10.0重量%、好ましくは0.02〜7.0重量%の範囲である。また、毛髪用化粧料の場合は、抽出物の固形分として、一般的には0.00001〜5.0重量%(固形分重量%、以下同じ)であり、好ましくは、0.0001〜3.0重量%である。また、美容用経口組成物におけるモモの未成熟果実の抽出物の配合量は、抽出物の固形分として、0.1〜15重量%の範囲が好ましい。 The blending amount of the immature peach fruit extract in the cosmetics is generally 0.002 to 1.0% by weight, preferably 0.02 to 0.2 in the case of basic cosmetics, as the solid content of the extract. In the range of% by weight, in the case of make-up cosmetics, generally in the range of 0.002 to 1.0% by weight, preferably in the range of 0.02 to 0.2% by weight, and in the case of cleansing cosmetics, generally in the range of 0. It is in the range of 002 to 10.0% by weight, preferably 0.02 to 7.0% by weight. In the case of hair cosmetics, the solid content of the extract is generally 0.00001 to 5.0% by weight (solid content weight%, the same applies hereinafter), preferably 0.0001 to 3% by weight. It is 0.0% by weight. The blending amount of the immature peach fruit extract in the cosmetological oral composition is preferably in the range of 0.1 to 15% by weight as the solid content of the extract.
化粧料又は美容用経口組成物には、必須成分のモモの未成熟果実の抽出物のほかに、通常化粧料に用いられる成分、例えば油性成分、界面活性剤(合成系、天然物系)、保湿剤、増粘剤、防腐・殺菌剤、粉体成分、紫外線吸収剤、抗酸化剤、色素、香料等を必要に応じて適宜配合することができる。また、モモの未成熟果実の抽出物の有効性、特長を損なわない限り、他の生理活性成分を組み合わせて配合することも何ら差し支えない。 In addition to the essential ingredient peach immature fruit extract, cosmetics or cosmetological oral compositions include ingredients commonly used in cosmetics, such as oily ingredients, surfactants (synthetic and natural products), etc. Moisturizers, thickeners, preservatives / bactericides, powder components, ultraviolet absorbers, antioxidants, pigments, fragrances and the like can be appropriately blended as needed. In addition, as long as the effectiveness and characteristics of the immature fruit extract of peach are not impaired, other physiologically active ingredients may be combined and blended at all.
ここで、油性成分としては、例えばオリーブ油、ホホバ油、ヒマシ油、大豆油、米油、米胚芽油、ヤシ油、パーム油、カカオ油、メドウフォーム油、シアーバター、ティーツリー油、アボガド油、マカデミアナッツ油、植物由来スクワランなどの植物由来の油脂類;ミンク油、タートル油などの動物由来の油脂類;ミツロウ、カルナウバロウ、ライスワックス、ラノリンなどのロウ類;流動パラフィン、ワセリン、パラフィンワックス、スクワランなどの炭化水素類;ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、イソステアリン酸、cis−11−エイコセン酸などの脂肪酸類;ラウリルアルコール、セタノール、ステアリルアルコールなどの高級アルコール類;ミリスチン酸イソプロピル、パルミチン酸イソプロピル、オレイン酸ブチル、2−エチルヘキシルグリセライド、高級脂肪酸オクチルドデシル(ステアリン酸オクチルドデシル等)などの合成エステル類及び合成トリグリセライド類等が挙げられる。 Here, examples of the oily component include olive oil, jojoba oil, paraffin oil, soybean oil, rice oil, rice germ oil, palm oil, palm oil, cacao oil, meadowfoam oil, sheer butter, tea tree oil, and avocado oil. Plant-derived fats and oils such as macadamia nut oil and plant-derived squalane; animal-derived fats and oils such as mink oil and turtle oil; waxes such as beeswax, carnauba wax, rice wax, and lanolin; liquid paraffin, vaseline, paraffin wax, squalane, etc. Hydrocarbons; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, cis-11-eicosenoic acid; higher alcohols such as lauryl alcohol, cetanol, stearyl alcohol; isopropyl myristate, palmitic acid Examples thereof include synthetic esters such as isopropyl, butyl oleate, 2-ethylhexyl glyceride, higher fatty acid octyldodecyl (octyldodecyl stearate, etc.) and synthetic triglycerides.
界面活性剤としては、例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビトール脂肪酸エステルなどの非イオン界面活性剤;脂肪酸塩、アルキル硫酸塩、アルキルベンゼンスルホン酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、ポリオキシエチレン脂肪アミン硫酸塩、ポリオキシエチレンアルキルフェニルエーテル硫酸塩、ポリオキシエチレンアルキルエーテル燐酸塩、α−スルホン化脂肪酸アルキルエステル塩、ポリオキシエチレンアルキルフェニルエーテル燐酸塩などのアニオン界面活性剤;第四級アンモニウム塩、第一級〜第三級脂肪アミン塩、トリアルキルベンジルアンモニウム塩、アルキルピリジニウム塩、2−アルキル−1−アルキル−1−ヒドロキシエチルイミダゾリニウム塩、N,N−ジアルキルモルフォルニウム塩、ポリエチレンポリアミン脂肪酸アミド塩などのカチオン界面活性剤;N,N−ジメチル−N−アルキル−N−カルボキシメチルアンモニオベタイン、N,N,N−トリアルキル−N−アルキレンアンモニオカルボキシベタイン、N−アシルアミドプロピル−N′,N′−ジメチル−N′−β−ヒドロキシプロピルアンモニオスルホベタインなどの両性界面活性剤等を使用することができる。 Examples of the surfactant include polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, and poly. Nonionic surfactants such as oxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkylbenzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty amine sulfates, polyoxyethylene alkylphenyl ether sulfates, Anionic surfactants such as polyoxyethylene alkyl ether phosphates, α-sulfonated fatty acid alkyl ester salts, polyoxyethylene alkyl phenyl ether phosphates; quaternary ammonium salts, primary to tertiary fatty amine salts, tris. Cationic surfactants such as alkylbenzylammonium salt, alkylpyridinium salt, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salt, N, N-dialkylmorphonium salt, polyethylene polyamine fatty acid amide salt; N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine, N, N, N-trialkyl-N-alkylene ammoniocarboxybetaine, N-acylamide propyl-N', N'-dimethyl-N'- Amphoteric surfactants such as β-hydroxypropylammoniosulfobetaine can be used.
乳化剤乃至乳化助剤としては、酵素処理ステビアなどのステビア誘導体、レシチン及びその誘導体(水素添加レシチン等)、乳酸菌醗酵米、乳酸菌醗酵発芽米、乳酸菌醗酵穀類(麦類、豆類、雑穀など)等を配合することもできる。 Examples of emulsifiers or emulsifying aids include stevia derivatives such as enzyme-treated stevia, lecithin and its derivatives (hydrogenated lecithin, etc.), lactic acid bacteria fermented rice, lactic acid bacteria fermented germinated rice, lactic acid bacteria fermented grains (wheat, beans, miscellaneous grains, etc.). It can also be blended.
保湿剤としては、例えばグリセリン、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコール、ソルビトール、キシリトール、ピロリドンカルボン酸ナトリウム等があり、さらにトレハロース等の糖類、ムコ多糖類(例えば、ヒアルロン酸及びその誘導体、コンドロイチン及びその誘導体、ヘパリン及びその誘導体など)、エラスチン及びその誘導体、コラーゲン及びその誘導体、NMF関連物質、乳酸、尿素、高級脂肪酸オクチルドデシル、海藻抽出物、シラン根(白及)抽出物、各種アミノ酸及びそれらの誘導体が挙げられる。 Examples of the moisturizing agent include glycerin, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidone carboxylate and the like, and saccharides such as trehalose and mucopolysaccharides (for example, hyalurone). Acids and their derivatives, chondroitin and its derivatives, heparin and its derivatives, etc.), elastin and its derivatives, collagen and its derivatives, NMF-related substances, lactic acid, urea, higher fatty acids octyldodecyl, seaweed extract, silane roots Examples include extracts, various amino acids and their derivatives.
増粘剤としては、例えばアルギン酸、寒天、カラギーナン、フコイダン等の褐藻、緑藻又は紅藻由来成分;シラン根(白及)抽出物;ペクチン、ローカストビーンガム、アロエ多糖体等の多糖類;キサンタンガム、トラガントガム、グアーガム等のガム類;カルボキシメチルセルロース、ヒドロキシエチルセルロース等のセルロース誘導体;ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸・メタクリル酸共重合体等の合成高分子類;ヒアルロン酸及びその誘導体;ポリグルタミン酸及びその誘導体等が挙げられる。 Examples of the thickener include ingredients derived from brown algae, green algae or red algae such as alginic acid, agar, carrageenan and fucoidan; silane root (white and) extract; polysaccharides such as pectin, locust bean gum and aloe polysaccharide; xanthan gum, Gum such as tragant gum and guar gum; cellulose derivatives such as carboxymethyl cellulose and hydroxyethyl cellulose; synthetic polymers such as polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, alginic acid / methacrylic acid copolymer; hyaluronic acid and its derivatives; poly Examples thereof include glutamate and derivatives thereof.
防腐・殺菌剤としては、例えば尿素;パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチルなどのパラオキシ安息香酸エステル類;フェノキシエタノール、ジクロロフェン、ヘキサクロロフェン、塩酸クロルヘキシジン、塩化ベンザルコニウム、サリチル酸、エタノール、ウンデシレン酸、フェノール類、ジャマール(イミダゾデイニールウレア)、1,2−ペンタンジオール、各種精油類、樹皮乾留物等がある。 Examples of preservatives and bactericides include urea; paraoxybenzoic acid esters such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and butyl paraoxybenzoate; phenoxyethanol, dichlorophenol, hexachlorophene, chlorhexidine hydrochloride, and benza chloride. There are luconium, salicylic acid, ethanol, undesyleneic acid, phenols, jamar (imidazodeini ruurea), 1,2-pentanediol, various essential oils, and dried bark.
粉体成分としては、例えばセリサイト、酸化チタン、タルク、カオリン、ベントナイト、酸化亜鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコニウム、硫酸バリウム、無水ケイ酸、雲母、ナイロンパウダー、ポリエチレンパウダー、シルクパウダー、セルロース系パウダー、穀類(米、麦、トウモロコシ、キビなど)のパウダー、豆類(大豆、小豆など)のパウダー等がある。 Examples of powder components include cericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, nylon powder, polyethylene powder, silk powder, and cellulose. There are system powders, grain powders (rice, wheat, corn, millet, etc.), beans (soybeans, red beans, etc.) powders, etc.
紫外線吸収剤としては、例えばパラアミノ安息香酸エチル、パラジメチルアミノ安息香酸エチルヘキシル、サリチル酸アミル及びその誘導体、パラメトキシ桂皮酸2−エチルヘキシル、桂皮酸オクチル、オキシベンゾン、2,4−ジヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、4−ターシャリーブチル−4−メトキシベンゾイルメタン、2−(2−ヒドロキシ−5−メチルフェニル)ベンゾトリアゾール、ウロカニン酸、ウロカニン酸エチル、アロエ抽出物等がある。 Examples of the ultraviolet absorber include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and its derivatives, 2-ethylhexyl paramethoxycinnamate, octyl silicate, oxybenzone, 2,4-dihydroxybenzophenone, 2-hydroxy-4. -Methoxybenzophenone-5-sulfonate, 4-tershally butyl-4-methoxybenzoylmethane, 2- (2-hydroxy-5-methylphenyl) benzotriazole, urocanic acid, ethyl urocanate, aloe extract, etc. ..
抗酸化剤としては、例えばブチルヒドロキシアニソール、ブチルヒドロキシトルエン、没食子酸プロピル、ビタミンE及びその誘導体(例えば、ビタミンEニコチネート、ビタミンEリノレート等)等がある。 Antioxidants include, for example, butylhydroxyanisole, butylhydroxytoluene, propyl gallate, vitamin E and derivatives thereof (for example, vitamin E nicotinate, vitamin E linoleate, etc.).
美白剤としては、t−シクロアミノ酸誘導体、コウジ酸及びその誘導体、アスコルビン酸及びその誘導体、ハイドロキノン又はその誘導体、エラグ酸及びその誘導体、ニコチン酸及びその誘導体、レゾルシノール誘導体、トラネキサム酸及びその誘導体、4−メトキシサリチル酸カリウム塩、マグノリグナン(5,5'−ジプロピル−ビフェニル−2,2’−ジオール)、4−HPB(ロドデノール、4−(4−ヒドロキシフェニル)−4−ブタノール))、ヒドロキシ安息香酸及びその誘導体、ビタミンE及びその誘導体、α−ヒドロキシ酸、AMP(アデノシンモノホスフェイト、アデノシン1リン酸)が挙げられ、これらを単独で配合しても、複数を組み合わせて配合しても良い。 Whitening agents include t-cycloamino acid derivatives, kodiic acid and its derivatives, ascorbic acid and its derivatives, hydroquinone or its derivatives, ellagic acid and its derivatives, nicotinic acid and its derivatives, resorcinol derivatives, tranexamic acid and its derivatives, 4 -Potasium salicylate, magnolignan (5,5'-dipropyl-biphenyl-2,2'-diol), 4-HPB (rhododenol, 4- (4-hydroxyphenyl) -4-butanol), hydroxybenzoic acid And its derivatives, Vitamin E and its derivatives, α-hydroxyic acid, AMP (adenosine monophosphate, adenosine monophosphate), and these may be blended alone or in combination of two or more.
上記のコウジ酸誘導体としては、例えばコウジ酸モノブチレート、コウジ酸モノカプレート、コウジ酸モノパルミテート、コウジ酸ジブチレートなどのコウジ酸エステル類、コウジ酸エーテル類、コウジ酸グルコシドなどのコウジ酸糖誘導体等が、アスコルビン酸誘導体としては、例えばL−アスコルビン酸−2−リン酸エステルナトリウム、L−アスコルビン酸−2−リン酸エステルマグネシウム、L−アスコルビン酸−2−硫酸エステルナトリウム、L−アスコルビン酸−2−硫酸エステルマグネシウムなどのアスコルビン酸エステル塩類、L−アスコルビン酸−2−グルコシド、L−アスコルビン酸−5−グルコシドなどのアスコルビン酸糖誘導体、それらアスコルビン酸糖誘導体の6位アシル化物(アシル基は、ヘキサノイル基、オクタノイル基、デカノイル基など)、L−アスコルビン酸テトライソパルミチン酸エステル、L−アスコルビン酸テトララウリン酸エステルなどのL−アスコルビン酸テトラ脂肪酸エステル類、3−O−エチルアスコルビン酸、L−アスコルビン酸−2−リン酸−6−O−パルミテートナトリウム、グリセリルアスコルビン酸又はそのアシル化誘導体、ビスグリセリルアスコルビン酸等のアスコルビン酸グルセリン誘導体、L−アスコルビン酸リン酸アミノプロピル、L−アスコルビン酸のヒアルロン酸誘導体等が、ハイドロキノン誘導体としては、アルブチン(ハイドロキノン−β−D−グルコピラノシド)、α−アルブチン(ハイドロキノン−α−D−グルコピラノシド)等が、トラネキサム酸誘導体としては、トラネキサム酸エステル(例えば、トラネキサム酸ラウリルエステル、トラネキサム酸ヘキサデシルエステル、トラネキサム酸セチルエステル又はその塩)、トラネキサム酸のアミド体(例えば、トラネキサム酸メチルアミド)などが挙げられ、レゾルシノール誘導体としては、例えば、4−n−ブチルレゾルシノール、4−イソアミルレゾルシノール等が、2,5−ジヒドロキシ安息香酸誘導体としては、例えば2,5−ジアセトキシ安息香酸、2−アセトキシ−5−ヒドロキシ安息香酸、2−ヒドロキシ−5−プロピオニルオキシ安息香酸等が、ニコチン酸誘導体としては、例えばニコチン酸アミド、ニコチン酸ベンジル等が、α−ヒドロキシ酸としては、例えば乳酸、リンゴ酸、コハク酸、クエン酸、α−ヒドロキシオクタン酸等がある。 Examples of the ascorbic acid derivative include ascorbic acid esters such as ascorbic acid monobutyrate, ascorbic acid monocaplate, ascorbic acid monopalmitate, and ascorbic acid dibutyrate, ascorbic acid ethers, and ascorbic acid sugar derivatives such as ascorbic acid glucoside. However, examples of the ascorbic acid derivative include L-ascorbic acid-2-phosphate ester sodium, L-ascorbic acid-2-phosphate ester magnesium, L-ascorbic acid-2-sulfate sodium ester, and L-ascorbic acid-2. -Ascorbic acid ester salts such as magnesium sulfate, ascorbic acid sugar derivatives such as L-ascorbic acid-2-glucoside, L-ascorbic acid-5-glucoside, and 6-position acylated products of these ascorbic acid sugar derivatives (the acyl group is Hexanoyl group, octanoyl group, decanoyl group, etc.), L-ascorbic acid tetrafatty acid esters such as L-ascorbic acid tetraisopalmitic acid ester, L-ascorbic acid tetralauric acid ester, 3-O-ethylascorbic acid, L- Ascorbic acid-2-phosphate-6-O-palmitate sodium, glyceryl ascorbic acid or an acylated derivative thereof, ascorbic acid glucerin derivative such as bisglyceryl ascorbic acid, L-ascorbic acid phosphate aminopropyl, L-ascorbic acid As a hyaluronic acid derivative or the like, as a hydroquinone derivative, albutin (hydroquinone-β-D-glucopyranoside), α-albutin (hydroquinone-α-D-glucopyranoside) or the like, and as a tranexamic acid derivative, a tranexamic acid ester (for example, tranexam) Examples thereof include acid lauryl ester, tranexamic acid hexadecyl ester, tranexamic acid cetyl ester or a salt thereof), an amide form of tranexamic acid (for example, methylamide tranexamic acid), and examples of the resorcinol derivative include 4-n-butylresorcinol. As the 2,5-dihydroxybenzoic acid derivative, for example, 2,5-diacetoxybenzoic acid, 2-acetoxy-5-hydroxybenzoic acid, 2-hydroxy-5-propionyloxybenzoic acid and the like can be used. Examples of the nicotinic acid derivative include nicotinic acid amide and benzyl nicotinate, and examples of α-hydroxy acid include lactic acid, ascorbic acid, succinic acid, citric acid, α-hydroxyoctanoic acid and the like.
生理活性成分としては、美白成分として、例えば、胎盤抽出液、ソウハクヒ抽出物、ユキノシタ抽出物、シソ抽出物、米糠抽出物又はその加水分解物、白芥子抽出物又はその加水分解物、白芥子の発酵物、シャクヤク抽出物又はその加水分解物、乳酸菌醗酵米、ムラサキシキブ抽出物、ハス種子抽出物又はその加水分解物、ハス種子発酵物、党参抽出物、ハトムギ加水分解物、ハトムギ種子発酵物、ローヤルゼリー発酵物、酒粕発酵物、パンダヌス・アマリリフォリウス(Pandanus amaryllifolius Roxb.)抽出物、アルカンジェリシア・フラバ(Arcangelicia flava Merrilli)抽出物、カミツレ抽出物等が上げられ、抗老化成分として、サンゴ草抽出物、イネの葉の抽出物又はその加水分解物、ナス(水ナス、長ナス、賀茂ナス、米ナス等)抽出物又はその加水分解物、アンズ果実の抽出物、カタメンキリンサイ等の海藻の抽出物、アマモ等の海産顕花植物の抽出物、豆乳発酵物、クラゲ水、米抽出物又はその加水分解物、米醗酵エキス、発芽米抽出物又はその加水分解物、発芽米発酵物、黒豆抽出物又はその加水分解物、ダマスクバラの花の抽出物、タケノコの皮の抽出物、リノール酸及びその誘導体もしくは加工物(例えばリポソーム化リノール酸など)、動物又は魚由来のコラーゲン及びその誘導体、エラスチン及びその誘導体、グリチルリチン酸及びその誘導体(ジカリウム塩等)、t−シクロアミノ酸誘導体、ビタミンA及びその誘導体、アラントイン、ジイソプロピルアミンジクロロアセテート、γ−アミノ−β−ヒドロキシ酪酸、ゲンチアナ抽出物、甘草抽出物、ニンジン抽出物、アロエ抽出物、ミツイシコンブ抽出物、ヘチマ抽出物、アナアオサ抽出物、ジュアゼイロ(Zizyphus joazeiro)抽出物等がある。 Physiologically active ingredients include, for example, placenta extract, sohakuhi extract, yukinoshita extract, perilla extract, rice bran extract or its hydrolyzate, white potato extract or its hydrolyzate, white potato extract. Fermented product, Shakyaku extract or its hydrolyzate, Lactobacillus fermented rice, Murasakikibu extract, Hass seed extract or its hydrolyzate, Hass seed fermented product, Ginseng extract, Hatomugi hydrolyzate, Hatomugi seed fermented product, Royal jelly Fermented product, fermented sake lees, Pandanus amaryllifolius Roxb. Extract, Arcangelicia flava Merrilli extract, chamomile extract, etc. are listed, and coral grass extract is used as an anti-aging component. Extract of rice leaf extract or its hydrolyzate, eggplant (water eggplant, long eggplant, Kamo eggplant, rice eggplant, etc.) extract or its hydrolyzate, apricot fruit extract, seaweed extract such as catamen giraffe Extracts of marine flowering plants such as amamo, fermented soymilk, jellyfish water, rice extract or its hydrolyzate, fermented rice extract, sprouted rice extract or its hydrolyzate, sprouted rice fermented product, black bean extract Fermented material or its hydrolyzate, damask rose flower extract, bamboo shoot skin extract, linoleic acid and its derivatives or processed products (eg liposomal linoleic acid, etc.), animal or fish-derived collagen and its derivatives, elastin And its derivatives, glycyrrhizic acid and its derivatives (dipotassium salt, etc.), t-cycloamino acid derivatives, vitamin A and its derivatives, allantin, diisopropylamine dichloroacetate, γ-amino-β-hydroxybutyric acid, gentian extract, licorice extract , Carrot extract, Aloe extract, Mitsuishikonbu extract, Hechima extract, Anaaosa extract, Zizyphus joazeiro extract and the like.
次に、製造例、実施例(処方例)及び試験例によって本発明をさらに具体的に説明するが、本発明はそれらに限定されるものではない。なお、以下において、部はすべて重量部を、また%はすべて重量%を意味する。 Next, the present invention will be described in more detail with reference to Production Examples, Examples (Prescription Examples) and Test Examples, but the present invention is not limited thereto. In the following, all parts mean parts by weight, and% means all parts by weight.
製造例1.モモの未成熟果実のエキスの調製
モモ(Prunus persica Batsch)の未成熟果実60gに精製水600gを混合し、静置した状態で、80℃下において2時間抽出を行い、抽出物溶液450.1gを得た。その後、得られた抽出物溶液をろ過し、さらに、ろ過した溶液に対して1%の活性炭(和光純薬株式会社製)を添加して活性炭処理を1時間行い、淡褐色のモモの未成熟果実の抽出物溶液431.0gを得た(pH4.1、固形分濃度3.50%)。
Production example 1. Preparation of peach immature fruit extract 600 g of immature fruit of peach (Plumus persica Bach) is mixed with 600 g of purified water, and the extract solution is extracted at 80 ° C. for 2 hours in a standing state, and the extract solution is 450.1 g. Got Then, the obtained extract solution was filtered, and 1% of activated carbon (manufactured by Wako Pure Chemical Industries, Ltd.) was added to the filtered solution to perform activated carbon treatment for 1 hour, and the light brown peach was immature. 431.0 g of a fruit extract solution was obtained (pH 4.1, solid content concentration 3.50%).
比較製造例1.モモの成熟果実のエキスの調製
モモ(Prunus persica Batsch)の成熟果実(皮、種子付き乾燥物)15gに精製水150gを混合し、静置した状態で、80℃下において、2時間抽出を行った。その後、モモの成熟果実の抽出物溶液110.5gを得た。その後、得られた抽出物溶液をろ過し、さらに、ろ過した溶液に対して1%の活性炭(和光純薬株式会社製)を添加して活性炭処理を1時間行い、モモの成熟果実の抽出物溶液を得た(pH5.0、固形分濃度7.30%)。
Comparative manufacturing example 1. Preparation of extract of mature peach fruit 150 g of purified water was mixed with 15 g of mature fruit (skin, dried product with seeds) of peach (Plumus persica Bach), and the mixture was left to stand and extracted for 2 hours at 80 ° C. rice field. Then, 110.5 g of the extract solution of the mature fruit of peach was obtained. Then, the obtained extract solution was filtered, and 1% of activated carbon (manufactured by Wako Pure Chemical Industries, Ltd.) was added to the filtered solution to perform activated carbon treatment for 1 hour to extract the mature fruit of peach. A solution was obtained (pH 5.0, solid content concentration 7.30%).
実施例1.クリーム
[A成分] 部
流動パラフィン 5.0
パラフィン 5.0
グリセリルモノステアレート 2.0
ポリオキシエチレン(20)ソルビタンモノステアレート 6.0
フェノキシエタノール 0.1
[B成分] 部
製造例1の抽出物溶液 2.5
グリセリン 5.0
カルボキシメチルモノステアレート 0.1
精製水 全量が100部となる量
[C成分]
香料 適量
上記のA成分とB成分をそれぞれ80℃以上に加熱した後、攪拌混合した。これを50℃まで冷却した後、C成分を加えてさらに攪拌混合してクリームを得た。
Example 1. Cream [Ingredient A] Part Liquid paraffin 5.0
Paraffin 5.0
Glyceryl monostearate 2.0
Polyoxyethylene (20) Sorbitan Monostearate 6.0
Phenoxyethanol 0.1
[Component B] Extract solution of Part Production Example 1 2.5
Glycerin 5.0
Carboxymethyl monostearate 0.1
Amount of purified water totaling 100 parts [C component]
Appropriate amount of fragrance The above components A and B were heated to 80 ° C. or higher, and then stirred and mixed. After cooling this to 50 ° C., component C was added and further stirred and mixed to obtain a cream.
実施例2.乳液
[A成分] 部
流動パラフィン 6.0
オリーブ油 1.0
ポリオキシエチレン(20)ソルビタンモノステアレート 2.0
大豆レシチン 1.5
メチルパラベン 0.15
[B成分] 部
製造例1の抽出物溶液 2.0
グリセリン 3.0
1、3−ブチレングリコール 2.0
カルボキシメチルセルロース 0.3
コラーゲン 0.1
精製水 全量が100部となる量
[C成分]
香料 適量
上記のA成分とB成分をそれぞれ80℃以上に加熱した後、攪拌混合した。これを50℃まで冷却した後、C成分を加えてさらに攪拌混合して乳液を得た。
Example 2. Emulsion [Component A] Part Liquid paraffin 6.0
Olive oil 1.0
Polyoxyethylene (20) sorbitan monostearate 2.0
Soy lecithin 1.5
Methylparaben 0.15
[Component B] Part The extract solution of Production Example 1 2.0
Glycerin 3.0
1,3-butylene glycol 2.0
Carboxymethyl cellulose 0.3
Collagen 0.1
Amount of purified water totaling 100 parts
[C component]
Appropriate amount of fragrance The above components A and B were heated to 80 ° C. or higher, and then stirred and mixed. After cooling this to 50 ° C., the C component was added and further stirred and mixed to obtain a milky lotion.
実施例3.ローション
[A成分] 部
製造例1の抽出物溶液 2.0
エタノール 10.0
グリセリン 3.0
1、3−ブチレングリコール 2.0
フェノキシエタノール 0.2
クエン酸 0.1
クエン酸ナトリウム 0.3
カルボキシビニルポリマー 0.1
香料 適量
水酸化カリウム 適量
精製水 全量が100部となる量
上記の成分を混合してローションを得た。
Example 3. Lotion [Component A] Part Extraction Solution of Production Example 1 2.0
Ethanol 10.0
Glycerin 3.0
1,3-butylene glycol 2.0
Phenoxyethanol 0.2
Citric acid 0.1
Sodium citrate 0.3
Carboxyvinyl polymer 0.1
Perfume Appropriate amount Potassium hydroxide Appropriate amount Purified water Amount that makes the total amount 100 parts The above components were mixed to obtain a lotion.
実施例4.化粧水
[A成分] 部
オリーブ油 1.0
ポリオキシエチレン(5.5)セチルアルコール 5.0
[B成分] 部
製造例1の抽出物溶液 5.0
エタノール 5.0
グリセリン 5.0
1,3−ブチレングリコール 5.0
水酸化カリウム 適量
精製水 全量が100部となる量
[C成分] 部
香料 適量
A成分及びB成分をそれぞれ80℃以上に加温後、A成分にB成分を加えて攪拌し、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。これを50℃まで冷却した後、C成分を加えて攪拌混合し、さらに30℃以下まで冷却して化粧水を得た。
Example 4. Toner [A component] Part Olive oil 1.0
Polyoxyethylene (5.5) cetyl alcohol 5.0
[Component B] Extract solution of Part Production Example 1 5.0
Ethanol 5.0
Glycerin 5.0
1,3-butylene glycol 5.0
Potassium hydroxide Appropriate amount Purified water Amount that makes the total amount 100 parts
[Component C] Appropriate amounts of perfume A component and B component were heated to 80 ° C. or higher, and then B component was added to A component and stirred, and homogenized with hiscotron (5000 rpm) for 2 minutes. After cooling this to 50 ° C., the C component was added, stirred and mixed, and further cooled to 30 ° C. or lower to obtain a lotion.
実施例5.乳液
[A成分] 部
流動パラフィン 6.0
ホホバ油 1.0
ポリオキシエチレン(20)ソルビタンモノステアレート 2.0
大豆レシチン 1.5
メチルパラベン 0.15
エチルパラベン 0.03
[B成分]
製造例1の抽出物溶液 5.0
L−アスコルビン酸−2−グルコシド 2.0
水酸化カリウム 0.5
グリセリン 3.0
1、3−ブチレングリコール 2.0
カルボキシメチルセルロース 0.3
ヒアルロン酸ナトリウム 0.01
精製水 全量が100部となる量
[C成分]
香料 適量
上記のA成分とB成分をそれぞれ80℃以上に加熱した後、攪拌混合した。これを50℃まで冷却した後、C成分を加えてさらに攪拌混合して乳液を得た。
Example 5. Emulsion [Component A] Part Liquid paraffin 6.0
Jojoba oil 1.0
Polyoxyethylene (20) sorbitan monostearate 2.0
Soy lecithin 1.5
Methylparaben 0.15
Ethylparaben 0.03
[B component]
Extract solution of Production Example 1 5.0
L-ascorbic acid-2-glucoside 2.0
Potassium hydroxide 0.5
Glycerin 3.0
1,3-butylene glycol 2.0
Carboxymethyl cellulose 0.3
Sodium hyaluronate 0.01
Amount of purified water totaling 100 parts
[C component]
Appropriate amount of fragrance The above components A and B were heated to 80 ° C. or higher, and then stirred and mixed. After cooling this to 50 ° C., the C component was added and further stirred and mixed to obtain a milky lotion.
製造例6.乳液
実施例5のB成分中、L−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.5部に代えてL−アスコルビン酸−2−リン酸エステルマグネシウム2.0部を用いるほかは実施例と同様にして乳液を得た。
Production example 6. Emulsion In the B component of Example 5, 2.0 parts of L-ascorbic acid-2-phosphate ester magnesium is used instead of 2.0 parts of L-ascorbic acid-2-glucoside and 0.5 part of potassium hydroxide. Obtained a milky lotion in the same manner as in Examples.
実施例7.乳液
実施例5のB成分中、L−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.5部に代えてトラネキサム酸2.0部を用いるほかは実施例5と同様にして乳液を得た。
Example 7. Emulsion Emulsion in the same manner as in Example 5 except that 2.0 parts of tranexamic acid is used instead of 2.0 parts of L-ascorbic acid-2-glucoside and 0.5 part of potassium hydroxide in the B component of Example 5. Got
実施例8.乳液
実施例5のB成分中、L−アスコルビン酸−2−グルコシド2.0部及び水酸化カリウム0.5部に代えてアルブチン2.0部を用いるほかは実施例5と同様にして乳液を得た。
Example 8. Emulsion Emulsion was prepared in the same manner as in Example 5 except that 2.0 parts of arbutin was used instead of 2.0 parts of L-ascorbic acid-2-glucoside and 0.5 part of potassium hydroxide in the B component of Example 5. Obtained.
実施例9.乳液
[A成分] 部
流動パラフィン 6.0
ホホバ油 1.0
ポリオキシエチレン(20)ソルビタンモノステアレート 2.0
大豆レシチン 1.5
メチルパラベン 0.15
エチルパラベン 0.03
[B成分]
製造例1の抽出物溶液 5.0
L−アスコルビン酸−2−グルコシド 2.0
アルブチン 3.0
水酸化カリウム 0.5
グリセリン 3.0
1、3−ブチレングリコール 2.0
カルボキシメチルセルロース 0.3
ヒアルロン酸ナトリウム 0.01
精製水 全量が100部となる量
[C成分]
香料 適量
上記のA成分とB成分をそれぞれ80℃以上に加熱した後、攪拌混合した。これを50℃まで冷却した後、C成分を加えてさらに攪拌混合して乳液を得た。
Example 9. Emulsion [Component A] Part Liquid paraffin 6.0
Jojoba oil 1.0
Polyoxyethylene (20) sorbitan monostearate 2.0
Soy lecithin 1.5
Methylparaben 0.15
Ethylparaben 0.03
[B component]
Extract solution of Production Example 1 5.0
L-ascorbic acid-2-glucoside 2.0
Arbutin 3.0
Potassium hydroxide 0.5
Glycerin 3.0
1,3-butylene glycol 2.0
Carboxymethyl cellulose 0.3
Sodium hyaluronate 0.01
Amount of purified water totaling 100 parts
[C component]
Appropriate amount of fragrance The above components A and B were heated to 80 ° C. or higher, and then stirred and mixed. After cooling this to 50 ° C., the C component was added and further stirred and mixed to obtain a milky lotion.
実施例10.リキッドファンデーション
[A成分] 部
ステアリン酸 2.4
モノステアリン酸プロピレングリコール 2.0
セトステアリルアルコール 0.2
液状ラノリン 2.0
流動パラフィン 3.0
ミリスチン酸イソプロピル 8.5
プロピルパラベン 0.05
[B成分]
製造例1の抽出物溶液 2.0
カルボキシメチルセルロースナトリウム 0.2
ベントナイト 0.5
プロピレングリコール 4.0
トリエタノールアミン 1.1
メチルパラベン 0.1
精製水 全量が100部となる量
[C成分]
酸化チタン 8.0
タルク 4.0
着色顔料 適量
上記のA成分とB成分をそれぞれ加温した後混合攪拌した。これを再加温し、上記のC成分を添加して型に流し込み、室温になるまで攪拌してリキッドファンデーションを得た。
Example 10. Liquid foundation [A component] Stearic acid 2.4
Propylene glycol monostearate 2.0
Setostearyl alcohol 0.2
Liquid lanolin 2.0
Liquid paraffin 3.0
Isopropyl myristate 8.5
Propylparaben 0.05
[B component]
Extract solution of Production Example 1 2.0
Sodium Carboxymethyl Cellulose 0.2
Bentonite 0.5
Propylene glycol 4.0
Triethanolamine 1.1
Methylparaben 0.1
Amount of purified water totaling 100 parts [C component]
Titanium oxide 8.0
Talc 4.0
Appropriate amount of color pigment The above components A and B were heated and then mixed and stirred. This was reheated, the above C component was added and poured into a mold, and the mixture was stirred until it reached room temperature to obtain a liquid foundation.
実施例11.クリームファンデーション
[A成分] 部
ステアリン酸 5.0
セタノール 2.0
モノステアリン酸グリセリル 3.0
流動パラフィン 5.0
スクワラン 3.0
ミリスチン酸イソプロピル 8.0
ポリオキシエチレン(20)モノステアリン酸グリセリル 2.0
プロピルパラベン 0.1
[B成分] 部
製造例1の抽出物溶液 2.5
ソルビトール 3.0
1,3−ブチレングリコール 5.0
トリエタノールアミン 1.5
メチルパラベン 0.1
精製水 全量が100部となる量
[C成分] 部
酸化チタン 8.0
タルク 2.0
カオリン 5.0
ベントナイト 1.0
着色顔料 適量
[D成分] 部
香料 0.3
C成分を混合し、粉砕機で粉砕した。B成分を混合し、これに粉砕したC成分を加え、コロイドミルで均一分散させた。A成分及び均一分散させたB、C成分をそれぞれ80℃に加温後、B、C成分にA成分を攪拌しながら加え、さらにヒスコトロン(5000rpm)で2分間ホモジナイズを行った。これを50℃まで冷却した後、D成分を加えて攪拌混合し、さらに攪拌しながら30℃以下まで冷却してクリームファンデーションを得た。
Example 11. Cream Foundation [Ingredient A] Part Stearic Acid 5.0
Cetanol 2.0
Glyceryl monostearate 3.0
Liquid paraffin 5.0
Squalene 3.0
Isopropyl myristate 8.0
Polyoxyethylene (20) glyceryl monostearate 2.0
Propylparaben 0.1
[Component B] Part 2.5 Extract solution of Production Example 1
Sorbitol 3.0
1,3-butylene glycol 5.0
Triethanolamine 1.5
Methylparaben 0.1
Amount of purified water totaling 100 parts [C component] part Titanium oxide 8.0
Talc 2.0
Kaolin 5.0
Bentonite 1.0
Appropriate amount of coloring pigment [D component] Part fragrance 0.3
The C component was mixed and pulverized with a pulverizer. The B component was mixed, the pulverized C component was added thereto, and the mixture was uniformly dispersed with a colloid mill. After heating the A component and the uniformly dispersed B and C components to 80 ° C., the A component was added to the B and C components with stirring, and homogenization was further carried out with hiscotron (5000 rpm) for 2 minutes. After cooling this to 50 ° C., component D was added and mixed by stirring, and the mixture was further cooled to 30 ° C. or lower with stirring to obtain a cream foundation.
実施例12.ボディシャンプー
[A成分] 部
N−ラウロイルメチルアラニンナトリウム 25.0
ヤシ油脂肪酸カリウム液(40%) 26.0
ヤシ油脂肪酸ジエタノールアミド 3.0
メチルパラベン 0.1
[B成分] 部
製造例1の抽出物溶液 5.0
1,3−ブチレングリコール 2.0
精製水 全量が100部となる量
A成分及びB成分をそれぞれ80℃に加温して均一に溶解した後、A成分にB成分を加え、攪拌を続けて室温まで冷却してボディシャンプーを得た。
Example 12. Body shampoo [A component] Part N-lauroylmethylalanine sodium 25.0
Coconut oil fatty acid potassium solution (40%) 26.0
Coconut oil fatty acid diethanolamide 3.0
Methylparaben 0.1
[Component B] Part Extract solution of Production Example 1 5.0
1,3-butylene glycol 2.0
Amount of purified water totaling 100 parts A component and B component are each heated to 80 ° C and uniformly dissolved, then B component is added to A component, and stirring is continued to cool to room temperature to obtain a body shampoo. rice field.
処方例13.ヘアシャンプー
[A成分] 部
N−ヤシ油脂肪酸メチルタウリンナトリウム 10.0
ポリオキシエチレン(3)アルキルエーテル硫酸ナトリウム 20.0
ラウリルジメチルアミノ酢酸ベタイン 10.0
ヤシ油脂肪酸ジエタノールアミド 4.0
メチルパラベン 0.1
[B成分]
クエン酸 0.1
製造例1の抽出物 2.0
1,3−ブチレングリコール 2.0
精製水 全量が100部となる量
A成分及びB成分をそれぞれ80℃に加温して均一に溶解した後、A成分にB成分を加え、攪拌を続けて室温まで冷却してヘアシャンプーを得た。
Prescription example 13. Hair shampoo [A component] Part N-coconut oil fatty acid methyl taurine sodium 10.0
Polyoxyethylene (3) Alkyl Ether Sodium Sulfate 20.0
Betaine Lauryl Dimethylamino Acetate 10.0
Coconut oil fatty acid diethanolamide 4.0
Methylparaben 0.1
[B component]
Citric acid 0.1
Extract of Production Example 1 2.0
1,3-butylene glycol 2.0
Amount of purified water that makes up 100 parts A component and B component are each heated to 80 ° C and uniformly dissolved, then B component is added to A component, and stirring is continued to cool to room temperature to obtain a hair shampoo. rice field.
実施例14.ヘアコンディショナー
[A成分] 部
ポリオキシエチレン(10)硬化ヒマシ油 1.0
塩化ジステアリルジメチルアンモニウム 1.5
塩化ステアリルトリメチルアンモニウム 2.0
2−エチルヘキサン酸グリセリル 1.0
セタノール 3.2
ステアリルアルコール 1.0
メチルパラベン 0.1
[B成分]
製造例1の抽出物 2.0
1,3−ブチレングリコール 5.0
精製水 全量が100部となる量
A成分及びB成分をそれぞれ80℃に加温して均一に溶解した後、A成分にB成分を加え、攪拌を続けて室温まで冷却してヘアリンスを得た。
Example 14. Hair conditioner [Component A] Part Polyoxyethylene (10) Hardened castor oil 1.0
Distearyl dimethylammonium chloride 1.5
Stearyltrimethylammonium chloride 2.0
Glyceryl 2-ethylhexanoate 1.0
Cetanol 3.2
Stearyl alcohol 1.0
Methylparaben 0.1
[B component]
Extract of Production Example 1 2.0
1,3-butylene glycol 5.0
Amount of purified water totaling 100 parts A component and B component were each heated to 80 ° C. to uniformly dissolve them, then B component was added to A component, and stirring was continued to cool to room temperature to obtain a hair rinse. ..
処方例15.美容飲料
製造例1の抽出物 10.0
コラーゲン 8.0
クエン酸 0.1
甘味料(スクロース) 0.01
酸化防止剤(ビタミンC)0.01
精製水 全量が100部となる量
Prescription example 15. Extract of Beauty Beverage Production Example 1 10.0
Collagen 8.0
Citric acid 0.1
Sweetener (sucrose) 0.01
Antioxidant (vitamin C) 0.01
Amount of purified water totaling 100 parts
処方例16.錠剤
製造例1の抽出物 20.0
ビタミンC 20.0
脂肪酸エステル 10.0
乳酸カルシウム 20.0
乳糖 30.0
上記重量部の各成分を混合した後、加圧成形し、錠剤とした。
Prescription example 16. Extract of Tablet Production Example 1 20.0
Vitamin C 20.0
Fatty acid ester 10.0
Calcium lactate 20.0
Lactose 30.0
After mixing each component by weight, pressure molding was performed to obtain a tablet.
試験例1.正常ヒト表皮細胞の遺伝子発現評価試験
本試験においては、本発明に係るモモの未成熟果実の抽出物による、正常ヒト表皮細胞の遺伝子発現に与える影響について評価するため、以下の通り試験を行った。
[試験方法]
正常ヒト表皮細胞を増殖添加剤含有HuMediaKG2[クラボウ社製]にて6×105個/mLに調製し、φ6cmシャーレに1mLを播種して、5%CO2、飽和水蒸気下、37℃で培養した。24時間培養後、さらに、製造例1の抽出物(試料溶液)を含んだ培養液(培養液全量に対して溶液として終濃度が2.0%となるように当該抽出物を添加したもの)を添加して培養した。また、比較対照として、試料溶液に代えて、2.0%のPBS(−)溶液のみを含んだ培養液を添加したコントロール区を設定した。24時間培養後、それぞれの試験区の細胞をTrizol試薬(Invitrogen社製)1mLで回収した。回収した細胞に対してクロロホルム(和光純薬工業社製)200μL添加して撹拌混合し遠心分離機(TOMY社製/MX-160)で15,000rpm、4℃の条件下で15分間遠心分離した後、水層のみを400μL分取した。回収した水層にイソプロパノール(和光純薬工業社製)500μLを添加して撹拌混合し、15,000rpm、4℃の条件下で15分間遠心分離してtotalRNAの沈殿物を得た。totalRNAに75%エタノールを1mL添加して撹拌して洗浄し、15,000rpm、4℃条件下で15分間遠心分離して沈殿を回収した。回収したtotal RNAを所定のキット(PrimeScript RT reagent Kit with gDNA Eraser [Perfect Real Time](タカラバイオ社製))を用いて逆転写反応し、cDNAを合成した。合成したcDNAをサンプルとして、Thermal Cycler Dice(登録商標)Real Time System Single(タカラバイオ社製)、及びSYBR(登録商標)Premix Ex TaqTM II(Perfect Real Time)[タカラバイオ社製]を用いて、各種遺伝子の発現と、内部標準物質G3PDH遺伝子の発現の検出を行った。ここで、G3PDH(glyceraldehyde-3-phosphate dehydrogenase)は、ハウスキーピング遺伝子(多くの組織や細胞中に共通して一定量発現する遺伝子であって、常に発現され,細胞の維持,増殖に不可欠な遺伝子である)の一つであり、発現量が常に一定とされていることから、PCRの実験では内部標準として用いられるものである。試験結果は、G3PDH遺伝子の発現量を一定とした場合の、それぞれの試験区での各遺伝子の発現量を比較した。本試験系においては、コントロール区のそれぞれの遺伝子の発現量を100としたときの試験区でのその遺伝子の発現量の相対値を求めた。 試験結果を表1〜6に示す。
Test example 1. Gene expression evaluation test of normal human epidermal cells In this test, the following tests were conducted to evaluate the effect of the extract of immature peach fruit according to the present invention on gene expression of normal human epidermal cells. ..
[Test method]
Normal human epidermal cells are prepared at 6 × 10 5 cells / mL with HuMedia KG2 [manufactured by Kurabo Industries] containing a growth additive, 1 mL is seeded in a φ6 cm petri dish, and cultured at 37 ° C. under 5% CO 2 and saturated steam. did. After culturing for 24 hours, a culture solution containing the extract (sample solution) of Production Example 1 (the extract was added so that the final concentration of the solution was 2.0% with respect to the total amount of the culture solution). Was added and cultured. In addition, as a comparative control, a control group was set in which a culture solution containing only 2.0% PBS (−) solution was added instead of the sample solution. After culturing for 24 hours, the cells of each test group were collected with 1 mL of Trizol reagent (manufactured by Invitrogen). 200 μL of chloroform (manufactured by Wako Pure Chemical Industries, Ltd.) was added to the collected cells, stirred and mixed, and centrifuged at 15,000 rpm and 4 ° C. for 15 minutes with a centrifuge (TOMY Co., Ltd./MX-160). After that, only the aqueous layer was separated by 400 μL. 500 μL of isopropanol (manufactured by Wako Pure Chemical Industries, Ltd.) was added to the recovered aqueous layer, stirred and mixed, and centrifuged at 15,000 rpm for 15 minutes under the conditions of 4 ° C. to obtain a total RNA precipitate. 1 mL of 75% ethanol was added to the total RNA, stirred and washed, and the precipitate was collected by centrifugation at 15,000 rpm for 15 minutes under the condition of 4 ° C. The recovered total RNA was reverse-transcribed using a predetermined kit (PrimeScript RT reagent Kit with gDNA Eraser [Perfect Real Time] (manufactured by Takara Bio Inc.)) to synthesize cDNA. Using the synthesized cDNA as a sample, using Thermal Cycler Dice (registered trademark) Real Time System Single (manufactured by Takara Bio Inc.) and SYBR (registered trademark) Premix Ex TaqTM II (Perfect Real Time) [manufactured by Takara Bio Inc.]. The expression of various genes and the expression of the internal standard substance G3PDH gene were detected. Here, G3PDH (glyceraldehyde-3-phosphate dehydrogenase) is a housekeeping gene (a gene that is commonly expressed in a certain amount in many tissues and cells, is always expressed, and is essential for cell maintenance and proliferation. It is one of the above, and since the expression level is always constant, it is used as an internal standard in PCR experiments. The test results were compared with the expression level of each gene in each test group when the expression level of the G3PDH gene was constant. In this test system, the relative value of the expression level of the gene in the test group was determined when the expression level of each gene in the control group was 100. The test results are shown in Tables 1-6.
[表1]
[Table 1]
[表2]
[Table 2]
表1,2に示すように、本発明に係る製造例1の抽出物は、表皮細胞のヒアルロン酸を分解する酵素であるヒアルロノグルコサミニダーゼ(Hyaluronoglucosaminidase1 [HYAL1]、Hyaluronoglucosaminidase2 [HYAL2])をコードする遺伝子の発現を抑制することから、皮膚の保湿機能を改善することができる。 As shown in Tables 1 and 2, the extract of Production Example 1 according to the present invention is a gene encoding hyaluronoglucosaminidase1 [HYAL1], Hyaluronoglucosaminidase2 [HYAL2], which is an enzyme that decomposes hyaluronic acid in epidermal cells. The moisturizing function of the skin can be improved by suppressing the expression of.
[表3]
[Table 3]
[表4]
[Table 4]
表3,4に示すように、本発明に係る製造例1の抽出物は、表皮細胞の基底膜を構成するIV型コラーゲンを分解する酵素であるマトリックスメタロプロテアーゼ(matrix metalloproteinase2 [MMP2]、matrix metalloproteinase9 [MMP9])をコードする遺伝子の発現を抑制することから、表皮細胞の基底膜を保護し、皮膚の表層のターンオーバーを改善することができる。 As shown in Tables 3 and 4, the extract of Production Example 1 according to the present invention is a matrix metalloproteinase (matrix metalloproteinase2 [MMP2], matrix metalloproteinase 9) which is an enzyme that decomposes type IV collagen constituting the basement membrane of epidermal cells. By suppressing the expression of the gene encoding [MMP9]), it is possible to protect the basement membrane of epidermal cells and improve the turnover of the superficial layer of the skin.
[表5]
[Table 5]
表5に示すように、本発明に係る製造例1の抽出物は、炎症性サイトカインであるインターロイキン−1(Interleulin1 alpha [IL1A2])をコードする遺伝子の発現を抑制することから、皮膚の炎症及び色素沈着を抑制することができる。 As shown in Table 5, the extract of Production Example 1 according to the present invention suppresses the expression of the gene encoding the inflammatory cytokine interleukin-1 (Interleulin1 alpha [IL1A2]), and thus causes skin inflammation. And pigmentation can be suppressed.
[表6]
[Table 6]
表6に示すように、本発明に係る製造例1の抽出物は、活性酸素種の一つである一酸化窒素(NO)合成酵素(Nitric Oxide Synthase [NOS2])をコードする遺伝子の発現を抑制することから、細胞の酸化ダメージを抑制し、さらには、活性酸素により生じる皮膚の色素沈着を抑制することができる。 As shown in Table 6, the extract of Production Example 1 according to the present invention expresses a gene encoding nitric oxide synthase (NOS2], which is one of the active oxygen species. By suppressing it, it is possible to suppress oxidative damage to cells and further suppress skin pigmentation caused by active oxygen.
試験例2.正常ヒト線維芽細胞の遺伝子発現評価試験
本試験においては、本発明に係るモモの未成熟果実の抽出物による、正常ヒト線維芽細胞の遺伝子発現に与える影響について評価するため、以下の通り試験を行った。
[試験方法]
正常ヒト線維芽細胞を0.5容量%NCS含有イーグルMEM(日水製薬社製)にて6×105個/mLに調製し、φ6cmシャーレに1mLを播種して、5%CO2、飽和水蒸気下、37℃で培養した。24時間培養後、さらに、本発明に係る製造例1の抽出物を含んだ培養液(培養液全量に対して溶液として終濃度が2.0%となるように当該抽出物を添加したもの)を添加して培養した。また、比較対照として、本発明に係る製造例1の抽出物に代えて、PBS(−)のみを含んだ培養液(培養液全量に対するPBS(−)の終濃度を2.0%に調整したもの)を添加した試験区(コントロール区)を設定した。24時間培養後、それぞれの試験区の細胞をTrizol試薬(Invitrogen社製)1mLで回収した。回収した細胞に対してクロロホルム(和光純薬工業社製)200μL添加して撹拌混合し遠心分離機(TOMY社製/MX-160)で15,000rpm、4℃の条件下で15分間遠心分離した後、水層のみを400μL分取した。回収した水層にイソプロパノール(和光純薬工業社製)500μLを添加して撹拌混合し、15,000rpm、4℃の条件下で15分間遠心分離してtotalRNAの沈殿物を得た。totalRNAに75%エタノールを1mL添加して撹拌して洗浄し、15,000rpm、4℃条件下で15分間遠心分離して沈殿を回収した。回収したtotal RNAを所定のキット(PrimeScript RT reagent Kit with gDNA Eraser (Perfect Real Time)(タカラバイオ社製))を用いて逆転写反応し、cDNAを合成した。合成したcDNAをサンプルとして、Thermal Cycler Dice(登録商標)Real Time System Single(タカラバイオ社製)、及びSYBR(登録商標)Premix Ex TaqTM II(Perfect Real Time)[タカラバイオ社製]を用いて、各種遺伝子の発現と、内部標準物質G3PDH遺伝子の発現の検出を行った。ここで、G3PDH(glyceraldehyde-3-phosphate dehydrogenase)は、ハウスキーピング遺伝子(多くの組織や細胞中に共通して一定量発現する遺伝子であって、常に発現され,細胞の維持,増殖に不可欠な遺伝子である)の一つであり、発現量が常に一定とされていることから、PCRの実験では内部標準として用いられるものである。試験結果は、G3PDH遺伝子の発現量を一定とした場合の、それぞれの試験区での各遺伝子の発現量を比較した。本試験系においては、コントロール区のそれぞれの遺伝子の発現量を100としたときの試験区でのその遺伝子の発現量の相対値を求めた。試験結果を表7〜15に示す。
Test example 2. Gene expression evaluation test of normal human fibroblasts In this test, in order to evaluate the effect of the immature fruit extract of the peach according to the present invention on the gene expression of normal human fibroblasts, the following tests were conducted. went.
[Test method]
Normal human fibroblasts were prepared in 6 × 10 5 cells / mL with Eagle MEM (manufactured by Nissui Pharmaceutical Co., Ltd.) containing 0.5% by volume NCS, and 1 mL was seeded in a φ6 cm petri dish to saturate with 5% CO 2. The cells were cultured at 37 ° C. under steam. After culturing for 24 hours, a culture solution containing the extract of Production Example 1 according to the present invention (the extract was added so that the final concentration of the solution was 2.0% with respect to the total amount of the culture solution). Was added and cultured. As a comparative control, the final concentration of PBS (-) with respect to the total amount of the culture solution was adjusted to 2.0% instead of the extract of Production Example 1 according to the present invention. The test group (control group) to which the product was added was set. After culturing for 24 hours, the cells of each test group were collected with 1 mL of Trizol reagent (manufactured by Invitrogen). 200 μL of chloroform (manufactured by Wako Pure Chemical Industries, Ltd.) was added to the collected cells, stirred and mixed, and centrifuged at 15,000 rpm and 4 ° C. for 15 minutes with a centrifuge (TOMY Co., Ltd./MX-160). After that, only the aqueous layer was separated by 400 μL. 500 μL of isopropanol (manufactured by Wako Pure Chemical Industries, Ltd.) was added to the recovered aqueous layer, stirred and mixed, and centrifuged at 15,000 rpm for 15 minutes under the conditions of 4 ° C. to obtain a total RNA precipitate. 1 mL of 75% ethanol was added to the total RNA, stirred and washed, and the precipitate was collected by centrifugation at 15,000 rpm for 15 minutes under the condition of 4 ° C. The recovered total RNA was reverse-transcribed using a predetermined kit (PrimeScript RT reagent Kit with gDNA Eraser (Perfect Real Time) (manufactured by Takara Bio Inc.)) to synthesize cDNA. Using the synthesized cDNA as a sample, using Thermal Cycler Dice (registered trademark) Real Time System Single (manufactured by Takara Bio Inc.) and SYBR (registered trademark) Premix Ex TaqTM II (Perfect Real Time) [manufactured by Takara Bio Inc.]. The expression of various genes and the expression of the internal standard substance G3PDH gene were detected. Here, G3PDH (glyceraldehyde-3-phosphate dehydrogenase) is a housekeeping gene (a gene that is commonly expressed in a certain amount in many tissues and cells, is always expressed, and is essential for cell maintenance and proliferation. It is one of the above, and since the expression level is always constant, it is used as an internal standard in PCR experiments. The test results were compared with the expression level of each gene in each test group when the expression level of the G3PDH gene was constant. In this test system, the relative value of the expression level of the gene in the test group was determined when the expression level of each gene in the control group was 100. The test results are shown in Tables 7 to 15.
[表7]
[Table 7]
表7に示すように、本発明に係る製造例1の抽出物は、真皮ヒアルロン酸の合成酵素であるヒアルロナンシンターゼ(Hyaluronan synthase2 [HAS2])をコードする遺伝子の発現を亢進することから、皮膚のハリ等を向上させることができる。 As shown in Table 7, the extract of Production Example 1 according to the present invention enhances the expression of the gene encoding Hyaluronan synthase2 [HAS2], which is a synthase of dermal hyaluronic acid. It is possible to improve the firmness and the like.
[表8]
[Table 8]
表8に示すように、本発明に係る製造例1の抽出物は、真皮エラスチン線維の構成タンパク質(Elastin microfibril interfacer1 [EMILIN1])をコードする遺伝子の発現を亢進することから、皮膚のハリ等を向上させることができる。 As shown in Table 8, the extract of Production Example 1 according to the present invention enhances the expression of the gene encoding the constituent protein of dermal elastin fiber (Elastin microfibril interfacer1 [EMILIN1]). Can be improved.
[表9]
[Table 9]
表9に示すように、本発明に係る製造例1の抽出物は、皮膚の基底膜を構成するプロテオグリカンの一種であるXVIII型コラーゲン(collagen, type XVIII, alpha 1 [COL18A1])をコードする遺伝子の発現を亢進することから、基底膜を構成するプロテオグリカンの合成を促進し、皮膚のターンオーバー等を改善することができる。 As shown in Table 9, the extract of Production Example 1 according to the present invention is a gene encoding XVIII type collagen (collagen, type XVIII, alpha 1 [COL18A1]), which is a kind of proteoglycan constituting the basement membrane of the skin. Since the expression of collagen is enhanced, the synthesis of proteoglycan constituting the basement membrane can be promoted, and skin turnover and the like can be improved.
[表10]
[Table 10]
表10に示すように、本発明に係る製造例1の抽出物は、炎症性物質であるプロスタグランジンI2の合成に関与する酵素(prostaglandin I2 synthase [PTGIS])をコードする遺伝子の発現を抑制することから、皮膚の炎症及び色素沈着を抑制することができる。 As shown in Table 10, the extract of Production Example 1 according to the present invention suppresses the expression of a gene encoding an enzyme (prostaglandin I2 synthase [PTGIS]) involved in the synthesis of prostaglandin I2, which is an inflammatory substance. Therefore, skin inflammation and pigmentation can be suppressed.
[表11]
[Table 11]
[表12]
[Table 12]
表11、12に示すように、本発明に係る製造例1の抽出物は、生体内の抗酸化物質であるグルタオンの存在下で、有害分子を解毒、及び酸化ストレス応答に関与するグルタチオンペルオキシダーゼ(glutathione peroxidase1 [GPX])やグルタチオン−S−トランスフェラーゼ(Glutathione S-transferase mu2 [GSTM2])をコードする遺伝子の発現を亢進することから、生体内の解毒効果、酸化ストレスによる障害、疾患を予防、改善することができる。 As shown in Tables 11 and 12, the extract of Production Example 1 according to the present invention detoxifies harmful molecules and is involved in the oxidative stress response in the presence of glutaone, which is an antioxidant in the living body. By enhancing the expression of genes encoding glutathione peroxidase1 [GPX]) and glutathione-S-transferase mu2 [GSTM2], it prevents and improves in vivo detoxification effects, disorders caused by oxidative stress, and diseases. can do.
[表13]
[Table 13]
[表14]
[Table 14]
表13、14に示すように、生体内のエネルギー代謝経路(TCA回路)において重要な役割を果たす酵素であるアコニターゼ(Aconitase1 [ACO1]、Aconitase2 [ACO2])をコードする遺伝子の発現を亢進することから、加齢によって低下する細胞内のエネルギー合成を活性化することができる。 As shown in Tables 13 and 14, it is necessary to enhance the expression of genes encoding aconitase (Aconitase1 [ACO1], Aconitase2 [ACO2]), which are enzymes that play an important role in the intracellular energy metabolism pathway (TCA cycle). Therefore, it is possible to activate intracellular energy synthesis that decreases with age.
[表15]
[Table 15]
表15に示すように、細胞外マトリックス(例えば、コラーゲン、プロテオグリカン、エラスチンなど)を分解する酵素であるメタロペプチダーゼの阻害剤(Metallopeptidase inhibitor3 [TIMP3])をコードする遺伝子の発現を亢進することから、細胞外マトリックスを保護することができる。 As shown in Table 15, since it enhances the expression of a gene encoding an inhibitor of metalloproteinase inhibitor3 [TIMP3], which is an enzyme that decomposes extracellular matrix (for example, collagen, proteoglycan, elastin, etc.), The extracellular matrix can be protected.
試験例3.線維芽細胞ATP合成亢進効果
ヒト真皮由来線維芽細胞NB1RGBを、0.5%NCS含有イーグル最少必須培地(日水製薬社製)を入れた96穴マイクロプレートに1×104個/穴播種し、37℃、5.0%CO2の条件下に1日間プレ培養した後、培地に製造例1の抽出物を試料溶液として2.5%の濃度(培地全量に対する試料溶液の溶液としての終濃度)となるように添加し、同条件でさらに3日間培養した。比較としてPBS(−)及び成熟桃エキスも2.5%の濃度となるように添加して同様に培養した。次に、培地を除去してPBS(−)を100μL/穴添加し、ATP発光試薬(東洋オービット社)を100μL/穴添加してマイクロプレートシェイカーで1分間撹拌後、23℃に設定したルミノメーター(TECAN社)で10分間静置して発光量を測定した。本試験系においては、PBS(−)2.5%添加区の発光量を100としたときの他の試験区での発光量の相対値を求めてATP合成率とした。
Test example 3. Fibroblast ATP synthesis enhancing effect Human dermal-derived fibroblast NB1RGB was seeded in 1 × 10 4 cells / hole in a 96-well microplate containing the minimum essential medium for eagle containing 0.5% NCS (manufactured by Nissui Pharmaceutical Co., Ltd.). After pre-culturing under the conditions of 37 ° C. and 5.0% CO 2 for 1 day, the extract of Production Example 1 was used as a sample solution in a medium at a concentration of 2.5% (the final solution of the sample solution with respect to the total amount of the medium). It was added so as to have a concentration of), and the cells were cultured under the same conditions for another 3 days. For comparison, PBS (−) and mature peach extract were also added to a concentration of 2.5% and cultured in the same manner. Next, the medium was removed, 100 μL / hole of PBS (-) was added, 100 μL / hole of ATP luminescent reagent (Toyo Orbit) was added, and the mixture was stirred with a microplate shaker for 1 minute and then luminometer set at 23 ° C. The amount of light emitted was measured by allowing it to stand for 10 minutes at (TECAN). In this test system, the relative value of the luminescence amount in the other test groups when the luminescence amount in the PBS (−) 2.5% addition group was set to 100 was calculated and used as the ATP synthesis rate.
試験例3の結果を表16に示す。
[表16]
The results of Test Example 3 are shown in Table 16.
[Table 16]
表16に示すように、本発明に係る製造例1の抽出物は、比較例1のモモ成熟果実の抽出物と比較して、格段にすぐれた線維芽細胞ATP合成亢進効果を有することが確認された。 As shown in Table 16, it was confirmed that the extract of Production Example 1 according to the present invention has a significantly superior effect of enhancing fibroblast ATP synthesis as compared with the extract of mature peach fruit of Comparative Example 1. Was done.
試験例4:フェノール類(ポリフェノール等)の確認試験
[試料]
製造例1のモモの未成熟果実の抽出物溶液(本発明試料1)
[試験方法]
まず、塩化第二鉄(和光純薬株式会社製)9gを精製水100mLに溶解し、塩化第二鉄溶液を調製した。次に、試料溶液1gに対して上記塩化第二鉄溶液を加えて、呈色具合を観察した。
[結果]
本発明試料1に塩化第二鉄溶液を加えても、試料溶液の色に変化は見られず、呈色反応は認められなかった。塩化第二鉄はフェノール類(ポリフェノール等)と反応して、緑〜黒青色を示すことから、本発明に係るモモの未成熟果実の抽出物にはフェノール類が含まれていないことが確認された。
Test Example 4: Confirmation test for phenols (polyphenols, etc.) [Sample]
Extract solution of immature fruit of peach of Production Example 1 (Sample 1 of the present invention)
[Test method]
First, 9 g of ferric chloride (manufactured by Wako Pure Chemical Industries, Ltd.) was dissolved in 100 mL of purified water to prepare a ferric chloride solution. Next, the above ferric chloride solution was added to 1 g of the sample solution, and the color development was observed.
[result]
Even when the ferric chloride solution was added to the sample 1 of the present invention, no change was observed in the color of the sample solution, and no color reaction was observed. Since ferric chloride reacts with phenols (polyphenols, etc.) and exhibits green to black-blue, it was confirmed that the extract of immature peach fruits according to the present invention does not contain phenols. rice field.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014028914A JP6910751B2 (en) | 2014-02-18 | 2014-02-18 | Moisturizers, anti-inflammatory agents, antioxidants, skin turnover improvers, cell activators and whitening agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014028914A JP6910751B2 (en) | 2014-02-18 | 2014-02-18 | Moisturizers, anti-inflammatory agents, antioxidants, skin turnover improvers, cell activators and whitening agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015151390A JP2015151390A (en) | 2015-08-24 |
JP6910751B2 true JP6910751B2 (en) | 2021-07-28 |
Family
ID=53894019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014028914A Active JP6910751B2 (en) | 2014-02-18 | 2014-02-18 | Moisturizers, anti-inflammatory agents, antioxidants, skin turnover improvers, cell activators and whitening agents |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6910751B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019052145A (en) * | 2017-09-13 | 2019-04-04 | 大正製薬株式会社 | Composition for controlling the production of various factors containing mitol production-promoting component as active ingredient, mitol production promoter, and method for screening agent for controlling the production of various factors with mitol production-promoting action as index |
KR102019632B1 (en) * | 2019-03-06 | 2019-09-06 | 휘조우 맨내이 바이오로지컬 테크놀로지 컴퍼니 리미티드 | Cosmetic composition for anti-aging containing extract of unripe fruits |
KR102195717B1 (en) * | 2020-08-27 | 2020-12-29 | 박선규 | Manufacturing Method of Cosmetic Composition Comprising Peach Fruit Extract and Cosmetic Composition Comprising thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08259453A (en) * | 1993-12-06 | 1996-10-08 | Nikka Uisukii Kk | Fruit juice containing fruit polyphenol, its production antioxidant, hypotensive agent, agent for antimutagenic action, suppressing agent for allergy, anticarious agent and deodorant |
JPH08151315A (en) * | 1994-11-25 | 1996-06-11 | Kanebo Ltd | Skin cosmetic |
JP2000136124A (en) * | 1998-10-30 | 2000-05-16 | Pias Arise Kk | Skin lotion |
US9000033B2 (en) * | 2008-07-31 | 2015-04-07 | Arch Personal Care Products, L.P. | Composition for improving skin condition and appearance |
ES2349972B1 (en) * | 2009-02-16 | 2011-11-24 | Lipotec, S.A. | USEFUL PEPTIDES IN THE TREATMENT AND / OR CARE OF SKIN, MUCOUSES AND / OR LEATHER LEATHER AND ITS USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS. |
JP5695308B2 (en) * | 2009-10-02 | 2015-04-01 | 株式会社フェース | Cosmetic base comprising collagen-modified liposome and skin cosmetic containing the same |
JP5812562B2 (en) * | 2009-11-20 | 2015-11-17 | 共栄化学工業株式会社 | Cosmetics |
-
2014
- 2014-02-18 JP JP2014028914A patent/JP6910751B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2015151390A (en) | 2015-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6884608B2 (en) | Compositions and external preparations for skin | |
JP6927660B2 (en) | Topical skin composition and oral composition | |
JP6246578B2 (en) | Skin cosmetics | |
JP6951908B2 (en) | Topical skin agent | |
JP7418853B2 (en) | Skin external preparations | |
JP6706017B2 (en) | Stem cell function maintenance agent | |
JP2017214349A (en) | Cosmetic and Oral Composition | |
JP6619548B2 (en) | Cosmetics | |
JP6754166B2 (en) | Cosmetics | |
JP6820645B2 (en) | Whitening composition and cosmetics | |
JP6910751B2 (en) | Moisturizers, anti-inflammatory agents, antioxidants, skin turnover improvers, cell activators and whitening agents | |
JP6677446B2 (en) | Cosmetics | |
JP2018193336A (en) | Skin external preparation | |
JP5900915B2 (en) | Whitening cosmetics | |
JP6571321B2 (en) | External composition for skin and oral composition | |
JP6723679B2 (en) | Cosmetics | |
JP6735225B2 (en) | External skin composition and oral composition | |
JP2021024805A (en) | External preparation for skin | |
JP6827691B2 (en) | Cosmetics | |
JP6559948B2 (en) | Skin turnover improver | |
JP5812562B2 (en) | Cosmetics | |
JP6498867B2 (en) | Moisturizing composition | |
JP6375087B2 (en) | Cosmetics | |
JP2016222622A (en) | Skin cosmetics and hair cosmetics | |
JP2019194174A (en) | Skin external preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170213 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20171114 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20171219 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180219 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20180731 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181030 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20181030 |
|
C11 | Written invitation by the commissioner to file amendments |
Free format text: JAPANESE INTERMEDIATE CODE: C11 Effective date: 20181211 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20181225 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20190121 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20190201 |
|
C211 | Notice of termination of reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C211 Effective date: 20190225 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20190524 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20190628 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20190821 |
|
C13 | Notice of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: C13 Effective date: 20191105 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200106 |
|
C141 | Inquiry by the administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C141 Effective date: 20200414 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20200422 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200615 |
|
C54 | Written response to inquiry |
Free format text: JAPANESE INTERMEDIATE CODE: C54 Effective date: 20200615 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20200615 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20200814 |
|
C30A | Notification sent |
Free format text: JAPANESE INTERMEDIATE CODE: C3012 Effective date: 20201030 |
|
C302 | Record of communication |
Free format text: JAPANESE INTERMEDIATE CODE: C302 Effective date: 20201130 |
|
C13 | Notice of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: C13 Effective date: 20201222 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210218 |
|
C23 | Notice of termination of proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C23 Effective date: 20210406 |
|
C03 | Trial/appeal decision taken |
Free format text: JAPANESE INTERMEDIATE CODE: C03 Effective date: 20210608 |
|
C30A | Notification sent |
Free format text: JAPANESE INTERMEDIATE CODE: C3012 Effective date: 20210615 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210707 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6910751 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |